Work

Abstract P4-22-23: Phase II trial of selinexor for metastatic triple negative breast cancer

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-p4-22-23

Authors: HS Han, R Ismail-Khan, D Carney, M Extermann, D Hogue, H Soliman, L Loftus, JK Lee, D Sullivan

Institution: Moffitt Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592536647

Cites:

Cited by:

Related to: 10